3.1 Publication Steering Committees: Charters, Roles & Scientific Governance

Publication Steering Committees: Charters, Roles & Scientific Governance

Purpose

A PSC may oversee:

• strategic and tactical publication planning;
• identification and prioritization of scientifically justified outputs;
• sequencing of primary and secondary reports;
• formation of output-specific author working groups;
• contributor and author discussions;
• venue-selection processes;
• review and approval workflows;
• data access and final checks;
• monitoring of progress and metrics;
• dispute escalation;
• prevention of duplicate or fragmented publication.

The committee should not predetermine favorable conclusions or function as a commercial launch body.

When a PSC Is Useful

A PSC can be valuable for a large multicenter trial, a program containing several studies, or a dataset supporting multiple distinct analyses. A small single-output project may use a simpler author working group. Governance should be proportionate to complexity and risk.

The Charter

Create the charter early and revisit it when circumstances change. Useful elements include:

Numbers in the charter should fit the project. A guide should not teach that all PSCs require 60% attendance, two-thirds voting, quarterly meetings, or an external-member majority unless a particular charter says so.

Membership

Choose members for relevant contributions and perspectives, which may include:

• investigators and other external researchers;
• sponsor scientists and publication professionals;
• statisticians, epidemiologists, HEOR experts, or data scientists;
• medical writers or editorial specialists;
• patient or caregiver partners where appropriate;
• regional experts;
• legal, regulatory, safety, or compliance advisers as needed.

Avoid selecting an external person because of prescribing volume, promotional value, or prestige alone. Sponsor employment does not itself bar scientific contribution or authorship. Conflicts and roles should be transparent.

Patient involvement should be purposeful, supported, accessible, and recognized. It is not an automatic requirement for every committee or output.

Committee Membership Is Not Authorship

PSC service may contribute to authorship, but it is not a byline entitlement. For each manuscript or presentation, assess actual work under the venue's criteria. Under the ICMJE default, a person must:

1. make a qualifying contribution;
2. draft or critically revise important intellectual content;
3. approve the final version;
4. accept accountability.

A member who attends only an initial planning meeting and then does not contribute to the output does not qualify automatically. With permission, their committee service may be acknowledged if appropriate.

Conversely, a sponsor employee, statistician, patient partner, or professional writer who meets every criterion should not be excluded based on role or affiliation.

Data Access and Review

Committee and author-group members need sufficient access to understand and verify the work. Access may use protocols, SAPs, validated tables, listings, figures, study reports, analysis datasets, or controlled environments. Privacy and data-security rules still apply.

Sponsor review can legitimately address accuracy, safety, legal, regulatory, confidentiality, or intellectual property. The process should be defined, documented, and timely. Improper actions include suppressing an unfavorable prespecified result, inserting an unsupported claim, or delaying publication solely for commercial timing.

“Authors have final responsibility” does not mean authors may ignore validated data or applicable legal requirements. It means they approve the work, remain accountable, and cannot transfer scientific responsibility to a sponsor or writer.

Decision-Making

Consensus is useful because publication decisions often require multidisciplinary judgment. If consensus is unavailable, use the charter's decision rule. Record:

• the question;
• evidence considered;
• conflicts;
• alternatives;
• decision and rationale;
• dissent where relevant;
• follow-up action.

Do not invent a vote merely to overpower a scientific concern. A majority cannot make an unsupported claim correct.

Disputes

Common disputes involve author qualification or order, interpretation, timing, access, venue, or sponsor comments. A defensible escalation path may include:

1. discussion within the author working group;
2. chair or PSC mediation;
3. application of the charter, agreement, protocol, and relevant guidance;
4. independent scientific, statistical, institutional, ethics, or legal review;
5. consultation with the journal or conference when submission-stage rules are involved.

No one should sign for an absent author or alter data to resolve a disagreement. An author who cannot approve the final version cannot remain on the byline under ICMJE criteria.

Safety-Result Scenario

A validated prespecified safety analysis shows more cardiovascular events in the intervention group. A proposal to omit it from the primary report merely to protect a launch is inconsistent with complete, balanced reporting. The committee should ensure the finding is accurately reported and contextualized according to the protocol, analysis plan, reporting guideline, and author judgment. A future safety paper may add detail but is not a reason to conceal material primary-report information.

Interpretation Scenario

The sponsor and an external author disagree about an exploratory biomarker. Neither affiliation decides the answer. Review the prespecification, analysis, data, limitations, and relevant expertise. Use the charter's escalation process and label exploratory work correctly. If an honest disagreement remains, the author group and journal may need a transparent account rather than an artificially unanimous claim.